Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample.

OBJECTIVE Intestinal pseudo-obstruction is a rare gastrointestinal complication in patients with SSc without large studies examining its prevalence or outcomes. We aimed to compare outcomes in SSc patients with intestinal pseudo-obstruction to patients with intestinal pseudo-obstruction secondary to other causes, and SSc patients without intestinal pseudo-obstruction. METHODS This is a case-control study using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample for the period 2002-2011. We included patients with the previously validated International Classification of Diseases-Clinical Modification-9 code 710.1 for SSc in combination with codes for intestinal pseudo-obstruction, and determined length of hospitalization and the risks for surgical procedures, use of total parenteral nutrition (TPN) and in-hospital mortality. RESULTS A total of 193 610 SSc hospitalizations occurred in the USA between 2002 and 2011, of which 5.4% (n = 10 386) were associated with a concurrent intestinal pseudo-obstruction diagnosis (cases). In-hospital mortality was 7.3%. In multivariate analyses, cases were more likely to die during the inpatient stay and to receive TPN than patients with idiopathic intestinal pseudo-obstruction (control group 1), patients with intestinal pseudo-obstruction and diabetes (control group 2), and SSc patients without intestinal pseudo-obstruction (control group 3). Cases had longer in-hospital stay than control groups 2 and 3, and were less likely to undergo surgical procedures than control groups 1 and 2. CONCLUSION Intestinal pseudo-obstruction is a rare cause of hospitalization in patients with SSc, but is associated with high in-hospital mortality in comparison with other SSc patients and those with intestinal pseudo-obstruction secondary to other causes.

[1]  T. Medsger,et al.  Severe organ involvement in systemic sclerosis with diffuse scleroderma. , 2000, Arthritis and rheumatism.

[2]  M. Baron,et al.  The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review , 2013, The Journal of Rheumatology.

[3]  R. Petty,et al.  Intestinal pseudo-obstruction as an initial presentation of systemic sclerosis in two children. , 1997, British journal of rheumatology.

[4]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[5]  D. Khanna,et al.  Small and Large Intestinal Involvement , 2012 .

[6]  M. Baron,et al.  Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management , 2012, Current Rheumatology Reports.

[7]  P. Ducrotte,et al.  Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up. , 2007, Rheumatology.

[8]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[9]  E. Krishnan,et al.  Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria , 2015, Scandinavian journal of rheumatology.

[10]  A. Herrick,et al.  Home parenteral nutrition--an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. , 2007, Rheumatology.

[11]  J. Piette,et al.  Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. , 1999, Arthritis and rheumatism.

[12]  Brenda W Gillespie,et al.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. , 2003, Arthritis and rheumatism.

[13]  C. Sninsky,et al.  Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction , 1995, Digestive Diseases and Sciences.

[14]  Hirokazu Takahashi,et al.  An Epidemiologic Survey of Chronic Intestinal Pseudo-Obstruction and Evaluation of the Newly Proposed Diagnostic Criteria , 2012, Digestion.

[15]  N. Sandorfi,et al.  Mortality, Recurrence, and Hospital Course of Patients with Systemic Sclerosis-related Acute Intestinal Pseudo-obstruction , 2014, The Journal of Rheumatology.